India's Food Safety and Standards Authority (FSSAI) has officially banned the use of ashwagandha leaves and their extracts from wellness supplements. This significant decision, influenced by safety concerns raised by the Ayush Ministry, specifies that only the roots of the traditional Ayurvedic shrub are permissible for use in such products. The directive, issued on April 16, requires state authorities to take strict vigilance and legal action against any food business operators found non-compliant.
What is Ashwagandha?
Ashwagandha (Withania somnifera) is a small evergreen shrub with a rich history of over 3,000 years in Ayurvedic medicine. Its root extracts are traditionally valued for their potential to reduce cortisol levels, enhance sleep quality, and support muscle recovery and male fertility.
Why the Ban on Ashwagandha Leaves?
The FSSAI's clarification emphasizes that while ashwagandha roots remain permitted, the use of leaves—whether crude, extracted, or in any other form—is now prohibited. This restriction stems primarily from a lack of sufficient safety data regarding leaf consumption. Furthermore, traditional Ayurvedic texts predominantly endorse the root for internal use, with little mention of leaves for such purposes. Recent scientific studies have also indicated that ashwagandha leaves can contain high concentrations of reactive compounds, such as withaferin-A, which may pose serious health risks, including potential liver damage.
Impact on the Wellness Industry
This regulatory change is expected to significantly affect prominent companies in the wellness sector that offer ashwagandha products, including major players like Himalaya Wellness, Dabur India, Patanjali Ayurveda, Baidyanath, Zandu, and Emami. Manufacturers are now explicitly required to clearly state the specific plant parts used in their product labeling to ensure consumer transparency.
Who Should Exercise Caution with Ashwagandha?
Doctors generally advise pregnant individuals to avoid ashwagandha due to historical links with spontaneous abortion. Those with autoimmune diseases or thyroid conditions should also exercise caution or consult a healthcare professional before use. Ashwagandha can interact with various medications, including sedatives, immunosuppressants, and drugs for diabetes, high blood pressure, or thyroid issues. Potential mild side effects of ashwagandha consumption include upset stomach, nausea, diarrhea, and drowsiness.
Cultivation and Global Reach
In India, ashwagandha is primarily cultivated in dry, subtropical regions across states like Madhya Pradesh, Rajasthan, Gujarat, Maharashtra, Uttar Pradesh, Punjab, and Haryana, with Madhya Pradesh alone dedicating over 5,000 hectares to the crop. Globally, ashwagandha has gained considerable popularity, particularly in North America and Europe, where it is sold in various forms such as gummies, capsules, tea blends, and fortified beverages.